Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. George Frey | Bloomberg | Getty ImagesSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new heights...